Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ChemSusChem ; 15(2): e202102340, 2022 Jan 21.
Article in English | MEDLINE | ID: mdl-34826212

ABSTRACT

Electrochemical CO2 reduction (CO2 RR) is a key technology to convert greenhouse gas CO2 to value-added products, such as CO and formic acid (HCOOH). In the present study, two-dimensional Cu- and Al-based layered double hydroxides (Cu-Al/LDHs) were applied as CO2 RR catalysts. The catalysts were synthesized using a simple co-precipitation method employing sodium carbonate solutions with different pH and synthesis temperatures. The elemental ratio of Cu and Al, and sheet size were controlled. The most active Cu-Al/LDH showed a faradaic efficiency for CO generation of 42 % and one for formate generation of 22 % at the current density of 50 mA using a gas diffusion electrode system under galvanostatic conditions. Our result indicates that the sheet size of the LDH sheet is a critical parameter for determining CO2 RR activity.

2.
J Infect Chemother ; 26(9): 873-881, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32565151

ABSTRACT

The nationwide surveillance on antimicrobial susceptibility of bacterial respiratory pathogens from the patients in Japan was conducted by the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2016. The isolates were collected from clinical specimens obtained from well-diagnosed adult patients with respiratory tract infections during the period between February 2016 and August 2016 by three societies. Antimicrobial susceptibility testing was conducted at the central reference laboratory according to the method recommended by Clinical Laboratory Standards Institute. Susceptibility testing was evaluated in 1062 strains (143 Staphylococcus aureus, 210 Streptococcus pneumoniae, 17 Streptococcus pyogenes, 248 Haemophilus influenzae, 151 Moraxella catarrhalis, 134 Klebsiella pneumoniae, and 159 Pseudomonas aeruginosa). Ratio of methicillin-resistant S. aureus was 48.3%, and those of penicillin-susceptible S. pneumoniae was 99.5%. Among H. influenzae, 14.1% of them were found to be ß-lactamase-producing ampicillin-resistant strains, and 41.1% to be ß-lactamase-non-producing ampicillin-resistant strains. Extended spectrum ß-lactamase-producing K. pneumoniae and multi-drug resistant P. aeruginosa with metallo ß-lactamase were 4.5% and 0.6%, respectively.


Subject(s)
Communicable Diseases , Methicillin-Resistant Staphylococcus aureus , Respiratory Tract Infections , Adult , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Communicable Diseases/drug therapy , Drug Resistance, Bacterial , Haemophilus influenzae , Humans , Japan/epidemiology , Microbial Sensitivity Tests , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/epidemiology
3.
J Infect Chemother ; 25(9): 657-668, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31196772

ABSTRACT

The nationwide surveillance on antimicrobial susceptibility of bacterial respiratory pathogens from the patients in Japan was conducted by Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2014. The isolates were collected from clinical specimens obtained from well-diagnosed adult patients with respiratory tract infections during the period between January 2014 and April 2015 by three societies. Antimicrobial susceptibility testing was conducted at the central reference laboratory according to the method recommended by Clinical Laboratory Standards Institute. Susceptibility testing was evaluated in 1534 strains (335 Staphylococcus aureus, 264 Streptococcus pneumoniae, 29 Streptococcus pyogenes, 281 Haemophilus influenzae, 164 Moraxella catarrhalis, 207 Klebsiella pneumoniae, and 254 Pseudomonas aeruginosa). Ratio of methicillin-resistant S. aureus was 43.6%, and those of penicillin-susceptible S. pneumoniae was 100%. Among H. influenzae, 8.2% of them were found to be ß-lactamase-producing ampicillin-resistant strains, and 49.1% to be ß-lactamase-non-producing ampicillin-resistant strains. Extended spectrum ß-lactamase-producing K. pneumoniae and multi-drug resistant P. aeruginosa with metallo ß-lactamase were 9.2% and 0.4%, respectively.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Epidemiological Monitoring , Respiratory Tract Infections/prevention & control , Antimicrobial Stewardship , Haemophilus influenzae/drug effects , Humans , Japan/epidemiology , Klebsiella pneumoniae/drug effects , Methicillin-Resistant Staphylococcus aureus/drug effects , Microbial Sensitivity Tests , Moraxella catarrhalis/drug effects , Pseudomonas aeruginosa/drug effects , Respiratory Tract Infections/microbiology , Streptococcus pneumoniae/drug effects , Streptococcus pyogenes/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL